Synovus Financial’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.33M | Buy |
22,326
+773
| +4% | +$80.7K | 0.03% | 327 |
|
|
2025
Q1 | $2.51M | Buy |
21,553
+5,425
| +34% | +$633K | 0.03% | 305 |
|
|
2024
Q4 | $1.36M | Buy |
16,128
+278
| +2% | +$23.5K | 0.02% | 412 |
|
|
2024
Q3 | $1.42M | Buy |
15,850
+18
| +0.1% | +$1.62K | 0.02% | 436 |
|
|
2024
Q2 | $1.27M | Buy |
15,832
+178
| +1% | +$14.3K | 0.02% | 410 |
|
|
2024
Q1 | $1.25M | Buy |
+15,654
| New | +$1.25M | 0.02% | 409 |
|